Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-042033
Filing Date
2008-02-28
Accepted
2008-02-28 17:19:40
Documents
9
Period of Report
2007-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 910100
2 EMPLOYMENT AGREEMENT BETWEEN LESLIE HUDSON, PH.D AND NABI dex1011.htm EX-10.11 33305
3 TRANSITION/TERMINATION AGREEMENT BETWEEN NABI AND FRESENIUS BIOTECH GMBH dex1026.htm EX-10.26 157940
4 MANUFACTURING SERVICES AGREEMENT dex1033.htm EX-10.33 139567
5 CONSENT OF ERNST & YOUNG LLP dex23.htm EX-23 3004
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 6483
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 6627
8 CERTIFICATION OF CEOAND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 4499
9 GRAPHIC g17865img_txgraph.jpg GRAPHIC 63652
  Complete submission text file 0001193125-08-042033.txt   1351044
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 08651814
SIC: 2836 Biological Products, (No Diagnostic Substances)